High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population

Clinical Chemistry

Volumn 60, Issue 2, 2014, Pages 389-398

  Hassan, Hicham Cheikh ^a,b   Howlin, Kenneth ^a   Jefferys, Andrew ^a   Spicer, Stephen T ^a,b   Aravindan, Ananthakrishnapuram N ^a   Suryanarayanan, Govindarajan ^a   Hall, Bruce M ^a   Cleland, Bruce D ^a   Wong, Jeffrey K ^a   Suranyi, Michael G ^a   Makris, Angela ^a,c  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; FEMALE; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; BLOOD; KAPLAN MEIER METHOD; MORTALITY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

AGED; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 84893518432     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.207142     Document Type: Article

References (29)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. United States Renal Data System 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012;59(1 Suppl 1):A7, e1-420.
2. McDonald S. Chapter 3: deaths. In: McDonald S, Hurst K, eds. The 34th annual ANZDATA report 2011 - data to 2010. http://www.anzdata.org.au/v1/report- 2011.html (Accessed December 2013).
3. De Jager DJ, Grootendorst DC, Jager KJ, Van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-9.
4. De Filippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-9.
5. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005;20:1880-8.
6. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088-96.
7. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
8. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
9. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-16.
10. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009;55:930-7.
11. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
12. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
13. Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ 2012;184:E260-8.
14. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009;55:1809-15.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. Desai AA, Nissenson A, Chertow GM, Farid M, Singh I, Van Oijen MG, et al. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int 2009;13:347-59.
17. Pianta TJ, Horvath AR, Ellis VM, Leonetti R, Moffat C, Josland EA, Brown MA. Cardiac highsensitivity troponin t measurement: a layer of complexity in managing hemodialysis patients. Nephrology 2012;17:636-41.
18. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, et al. Sensitive troponins-which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 2012;7:e47610.
19. Ooi DS, House AA. Cardiac troponin T in hemodialyzed patients. Clin Chem 1998;44:1410-6.
20. Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in endstage renal failure. Clin Chem 2000;46:1345-50.
21. Mongeon FP, Dorais M, Lorier JL, Froment D, Letendre E, Rinfret S. Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year. Open Cardiovasc Med J 2009;3:69-77.
22. Deegan PB, Lafferty ME, Blumsohn A, Henderson IS, McGregor E. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 2001;60:2399-405.
23. Havekes B, Van Manen JG, Krediet RT, Boeschoten EW, Vandenbroucke JP, Dekker FW; NECOSAD Study Group. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2006;47:823-9.
24. Wang AY, Lam CW, Wang M, Chan IH, Goggins WB, Yu CM, et al. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem 2007;53:882-9.
25. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysisdependent chronic renal failure. Clin Chim Acta 2010;411:936-9.
26. Roberts MA, MacMillan N, Hare DL, Ratnaike S, Sikaris K, Fraenkel MB, Ierino FL. Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list. Nephrology 2006;11:471-6.
27. Wang F, Ye P, Luo L, Xu R, Bai Y, Wu H. Association of glomerular filtration rate with highsensitivity cardiac troponin T in a communitybased population study in Beijing. PLoS One 2012;7:e38218.
28. Duman D, Tokay S, Toprak A, Duman D, Oktay A, Ozener IC, Unay O. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:962-7.
29. Han SH, Choi HY, Kim DK, Moon SJ, Lee JE, Yoo TH, et al. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease. Am J Nephrol 2009;29:129-35.